Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nimodipine Preventing Cognitive Impairment in Ischemic Cerebrovascular Events: A Randomized, Placebo-Controlled, Double-Blind Trial (NICE)

NCT01220622 is registered in ClinicalTrials.gov with Ministry of Science and Technology of the People´s Republic of China as lead sponsor.

NCT NCT01220622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01220622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nimodipine Preventing Cognitive Impairment in Ischemic Cerebrovascular Events: A Randomized, Placebo-Controlled, Double-Blind Trial (NICE)
Lead sponsor
Ministry of Science and Technology of the People´s Republic of China
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2010
Completion date
July 31, 2012
Enrollment
656 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment, stroke